Home › Stocks › NVCT

Nuvectis Pharma, Inc. (NVCT): insider buying, hedge funds & Congress trades

Nuvectis Pharma, Inc. (NVCT): 15 insider purchases in the last two years (1 opportunistic).

Insider buying

FiledInsiderSharesPriceValueType
Nov 6, 2025Kaplan Matthew L.
Director
11,000$5.84$64.2Kno history
Nov 6, 2025Sanchez Juan
Director
13,000$5.79$75.3Kno history
Nov 6, 2025Bentsur Ron
Director, Officer, TenPercentOwner
5,000$5.72$28.6Kopportunistic
Oct 29, 2025Mosseri Marlio Charles
TenPercentOwner
154,770$6.18$957.1Kno history
Jun 24, 2025Mosseri Marlio Charles
TenPercentOwner
5,603$7.99$44.8Kno history
Jun 20, 2025Mosseri Marlio Charles
TenPercentOwner
33,442$8.06$269.5Kno history
May 13, 2025Mosseri Marlio Charles
TenPercentOwner
21,167$8.11$171.7Kno history
May 12, 2025Mosseri Marlio Charles
TenPercentOwner
27,662$8.94$247.3Kno history
May 9, 2025Mosseri Marlio Charles
TenPercentOwner
27,411$8.60$235.6Kno history
Feb 11, 2025Mosseri Marlio Charles
TenPercentOwner
240,000$5.00$1.2Mno history
Dec 26, 2024Bentsur Ron
Director, Officer, TenPercentOwner
4,500$4.65$20.9Kno history
Dec 16, 2024Mosseri Marlio Charles
TenPercentOwner
17,000$4.70$79.9Kno history
Dec 16, 2024Mosseri Marlio Charles
TenPercentOwner
49,121$4.66$228.9Kno history
Nov 20, 2024Poradosu Enrique
Officer
2,000$4.99$10.0Kno history
Nov 18, 2024Bentsur Ron
Director, Officer, TenPercentOwner
20,000$4.92$98.4Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for NVCT

Free account. Know when insiders, famous funds or Congress trade it.

Start free